[1] China National Accreditation Service for Conformity Assessment. CNAS-RL02: 2018 Rules for Proficiency Testing[S]. Beijing: China National Accreditation Service for Conformity Assessment, 2018: 1. [2] WEI JJ, NING BM, HE L, et al.Evaluation of results obtained in proficiency testing or determination of dissolution of salicylic acid tablets[J]. Chinese Pharmaceutical Affairs(中国药事), 2014, 28(12): 1327-1330. [3] PEI YS, CAI T, CHEN C, et al.Study on pyrogen control of monophosphoryl lipid a adjuvant[J]. Chinese Pharmacological Bulletin(中国药理学通报), 2020, 36(8): 1174-1177. [4] China National Accreditation Service for Conformity Assessment. CNAS-GL002: 2018 guidance on Statistic treatment of proficiency testing results and performance evaluation[S]. Beijing: China National Accreditation Service for Conformity Assessment, 2018: 1. [5] ISO. Statistical methods for use in proficiency testing by interlaboratory comparison: ISO13528:2022[S/OL]. [2024-06-30]. https://www.iso.org/obp/ui/en/#iso:std:78879:en. [6] DU Y, CHEN C, CAI T, et al.Verification of bacterial endotoxin spectrophotometry[J]. Chinese Pharmacological Bulletin(中国药理学通报), 2022, 38(11): 1717-1722. [7] ZHANG Y, TAN DJ, CHANG Y, et al.Proficiency testing for the determination of oxytocin potency[J]. China Pharmacist(中国药事), 2021, 24(4): 777-780. [8] KAUFMAN DA, PERKS PH, GREENBERG RG, et al.Endotoxin content in neonatal formulas, fortification, and lactoferrin products: association with outcomes and guidance on acceptable limits[J]. Biometals, 2023, 36(3): 703-708. [9] SONDHI A, ADENIJI T, LINGDEN D, et al.Advances in endotoxin analysis[J]. Advances in Clinical Chemistry, 2024, 118: 1-34. [10] WESPEL M, GEISS M, NAGELE M, et al.The impact of endotoxin masking on the removal of endotoxin during manufacturing of a biopharmaceutical drug product[J]. Journal of Chromatography A, 2022, 1671: 462995. [11] SOLATI S, ZHANG T, TIMMAN S.The monocyte activation test detects potentiated cytokine release resulting from the synergistic effect of endotoxin and non-endotoxin pyrogens[J]. Innate Immunity, 2022, 28(3-4): 130-137. [12] BOLDEN J, KNIGHT M, MONTZ J, et al.It is time to reconsider the use of naturally-occurring endotoxins in endotoxin recovery studies: part 2 of a BioPhorum harmonized endotoxin recovery study[J]. Biologicals, 2024, 87: 101779. [13] SHERABA NS, HESHAM A, FAWZY M, et al.Advanced approaches for endotoxin detection and removal from snake antivenoms[J]. Toxicon, 2023, 222: 107003. [14] NEUN BW, DOBROVOLSKAIA MA.Current considerations and practical solutions for overcoming nanoparticle interference with LAL assays and minimizing endotoxin contamination[J]. Methods in Molecular Biology, 2024, 2789: 87-99. [15] SCHROMM AB, CORREA W, GISCH N, et al.Supramolecular assembly of micellar aggregates is the basis of low endotoxin recovery (LER) in a drug formulation that can be resolved by a whole blood assay[J]. Biomedicine & Pharmacotherapy, 2024, 173: 116286. [16] VIRZI GM, MATTIOTTI M, DE CAL M, et al.Endotoxin in sepsis: methods for LPS Detection and the use of omics techniques[J]. Diagnostics Basel, 2022, 13(1): 79. [17] THURMAN TL, LAHTI CJ, MATEFFY JM, et al.Comparison of pyrogen assays by testing products exhibiting low endotoxin recovery[J]. ALTEX-Alternatives to Animal Experimentation, 2023, 40(1): 117-124. |